In brief, our data indicated that inhibition of IL-8 derived from GCMSCs may overcome the immune escape induced by PD-L1 in GC cells and provide a potential strategy to enhance the efficacy of PD-L1 antibody immunotherapy in GC. Here, CD274 is linked to gastric cancer.